Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children

被引：0
|
作者：
Doaa Elsherbiny
Yuan Ren
Helen McIlleron
Gary Maartens
Ulrika S. H. Simonsson
机构：
[1] Uppsala University,Department of Pharmaceutical Biosciences
[2] University of Cape Town,Division of Clinical Pharmacology, Department of Medicine
来源：
European Journal of Clinical Pharmacology | 2010年 / 66卷
关键词：
Lopinavir; Ritonavir; Pharmacokinetics; HIV; Tuberculosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1017 / 1023
页数：6
相关论文
共 50 条
  • [31] Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir
    Moultrie, Harry
    McIlleron, Helen
    Sawry, Shobna
    Kellermann, Tracy
    Wiesner, Lubbe
    Kindra, Gurpreet
    Gous, Hermien
    Van Rie, Annelies
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (02) : 543 - 549
  • [32] Reasons for delay in initiation of antiretroviral therapy in a population of HIV-Infected South African children
    Feucht, U. D.
    Kinzer, M.
    Kruger, M.
    JOURNAL OF TROPICAL PEDIATRICS, 2007, 53 (06) : 398 - 402
  • [33] Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children
    Capparelli, EV
    Englund, JA
    Connor, JD
    Spector, SA
    McKinney, RE
    Palumbo, P
    Baker, CJ
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (02): : 133 - 140
  • [34] Lopinavir population pharmacokinetics on HIV-infected adults - body weight and co-treatments influence
    Pichault, M. Bouillon
    Bouillo-Pichault, M. A.
    Treluyer, J. M.
    Rey, E.
    Pons, G.
    Jullien, V.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 44 - 45
  • [35] Duration of hospitalization and appetite of HIV-infected South African children
    Mda, Siyazi
    van Raaij, Joop M. A.
    MacIntyre, Una E.
    de Villiers, Francois P. R.
    Kok, Frans J.
    MATERNAL AND CHILD NUTRITION, 2011, 7 (02): : 175 - 187
  • [36] Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children
    Puthanakit, Thanyawee
    van der Lugt, Jasper
    Bunupuradah, Torsak
    Ananworanich, Jintanat
    Gorowara, Meena
    Phasomsap, Chayapa
    Jupimai, Thidarat
    Boonrak, Pitch
    Pancharoen, Chitsanu
    Burger, David
    Ruxrungtham, Kiat
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (05) : 1080 - 1086
  • [37] The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individuals
    Decloedt, E. H.
    Mwansa-Kambafwile, J.
    van der Walt, J-S.
    McIlleron, H.
    Denti, P.
    Smith, P.
    Wiesner, L.
    Rangaka, M.
    Wilkinson, R. J.
    Maartens, G.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (03) : 333 - 335
  • [38] Long-term pharmacokinetics of amprenavir in combination with delavirdine in HIV-infected children
    Engelhorn, C
    Hoffmann, F
    Kurowski, M
    Stocker, H
    Kruse, G
    Notheis, G
    Belohradsky, BH
    Wintergerst, U
    AIDS, 2004, 18 (10) : 1473 - 1475
  • [39] Comment on: Pharmacokinetics and 48 week efficacy of low-dose lopinavir/ritonavir in HIV-infected children
    Neely, Michael N.
    Rakhmanina, Natella Y.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (04) : 808 - 809
  • [40] Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients
    Zhang, Jianping
    Hayes, Siobhan
    Sadler, Brian M.
    Minto, Ilisse
    Brandt, Julie
    Piscitelli, Steve
    Min, Sherene
    Song, Ivy H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 502 - 514
12345